On November 12, 2020 Selvita, one of the largest preclinical contract research organizations in Europe, reported that it will present at the 5th Medicinal Chemistry & Protein Degradation Summit taking place on November 16-17, 2020, as an entirely virtual event (Press release, Selvita, NOV 12, 2020, View Source;utm_medium=rss&utm_campaign=selvita-will-participate-in-the-upcoming-5th-medicinal-chemistry-protein-degradation-summit [SID1234570752]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation "Building a PROTACs Toolbox for Contract Research" will be held by Dr. Tom Coulter, Integrated Drug Discovery Director at Selvita, on Monday 16, 2020, at 15:50 GMT.

Throughout the whole event, Selvita’s team will be available at our virtual booth. It is a great opportunity to meet our representatives and discuss Selvita’s capabilities in the area of integrated drug discovery services.

To contact Selvita’s delegates at this conference, please contact us at: [email protected]

This year’s edition of the event brings together over 35 speakers to explore innovative new research in Protein Degradation and consider novel approaches to DNA Encoded Libraries, Phenotypic Screening, and implementing Artificial Intelligence in the drug discovery process.